IL16 and psoriasis: The genetic liability to psoriasis (odds ratio [OR]: 1.00078; 95% confidence interval [CI]: 1.00008–1.00148; P = .028479), ESAM (OR: 1.00208; 95% CI: 1.00019–1.00397; P = .031089), and IL-16 (OR: 1.00118; 95% CI: 1.00009–1.00227; P = .033826) were associated with higher AMI risks.